Hemispherx Biopharma Announces Key Dates and Timeline for Stockholder Participation in Rights Offering – GlobeNewswire

Hemispherx Biopharma Announces Key Dates and Timeline for Stockholder Participation in Rights Offering GlobeNewswire

OCALA, Fla., Feb. 06, 2019 (GLOBE NEWSWIRE) — Hemispherx Biopharma, Inc. (NYSE American: HEB) (“Hemispherx” or the “Company”), an immuno-pharma …